Risks, benefits of breast cancer screening, treatment still difficult to quantify

On the front of the Personal Journal of the Wall Street Journal, Melinda Beck discusses in “Health Journal” several studies suggesting that breast cancer may be overdiagnosed and overtreated.

Clinicians say there is not an effective way of deciding which breast cancer patients should skip treatment. Additionally, while some studies suggest that breast cancer screening may lead to unnecessary treatment for some, research suggests that screening can reduce breast cancer deaths.

Beck points out that tests are now available to predict which tumors will progress based on their genetics.

This entry was posted in General Health. Bookmark the permalink.